Physician

David F Williams, MD

According to 2025 Medicare claims, David Williams, MD (NPI: 1558359554) practices ophthalmology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is VITREO RETINAL SURGERY PLLC (NPI: 1891783965; TIN: 411608615) and primary practice location at 55435-3004.

Williams' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,168 traditional Medicare patients, billed 31,893 HCPCS/CPT codes, and received $5,007,490 in Medicare payments. The top billing code was Q5128 (Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg). Part D data shows 400 prescription claims across 189 beneficiaries totaling $14,245 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,896,203 to $5,007,490. In contrast, Part D prescription costs have declined steadily, from $31,643 to $14,245. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.9M$5.9M2015 Medicare payment: $2,896,203 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,982,742 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,934,284 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,541,217 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,879,775 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,333,804 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,508,392 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,467,286 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,514,727 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,007,490 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201586315,206$2,896,203
201676716,104$2,982,742
201775115,517$2,934,284
201882118,370$3,541,217
20191,37531,301$5,879,775
20201,28028,299$5,333,804
20211,37028,771$5,508,392
20221,21624,288$5,467,286
20231,23126,665$5,514,727
20241,16831,893$5,007,490

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2015 Drug cost: $31,643 (USD; Tot_Drug_Cst)2016 Drug cost: $28,118 (USD; Tot_Drug_Cst)2017 Drug cost: $20,230 (USD; Tot_Drug_Cst)2018 Drug cost: $26,734 (USD; Tot_Drug_Cst)2019 Drug cost: $28,939 (USD; Tot_Drug_Cst)2020 Drug cost: $25,227 (USD; Tot_Drug_Cst)2021 Drug cost: $25,375 (USD; Tot_Drug_Cst)2022 Drug cost: $21,722 (USD; Tot_Drug_Cst)2023 Drug cost: $17,186 (USD; Tot_Drug_Cst)2024 Drug cost: $14,245 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015204625$31,643
2016182580$28,118
2017150433$20,230
2018216685$26,734
2019194707$28,939
2020168502$25,227
2021200542$25,375
2022211456$21,722
2023209472$17,186
2024189400$14,245

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg37411,185$180
67028Injection of drug into eye6653,233$98
92014Established patient complete exam of visual system491624$94
92012Established patient problem focused exam of visual system5651,143$66
92134Imaging of retina1,1524,114$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1065,044$7,398
Atropine SulfateAtropine Sulfate141,006$1,412
Ketorolac TromethamineKetorolac Tromethamine482,307$1,124
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat503,664$1,053
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha701,505$912

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for David F. Williams, MD?

Tedicare shows public-source Medicare data for David F. Williams, MD (NPI 1558359554), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David F. Williams, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David F. Williams, MD?

David F. Williams, MD is linked to VITREO RETINAL SURGERY PLLC (billing NPI 1891783965) in the available physician profile data.

Does David F. Williams, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.